The Patent Finder

Terms ending in 2037

Amgen Inc.

Every in-force patent on Amgen Inc.'s record whose computed term ends in 2037, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 11,419,933Pharmaceutical Composition Comprising Bispecific Antibody Constructs
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 10,822,408Pacap Antibodies and Uses Thereof
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 10,857,229Treatment of Ovarian Cancer in Patients with Ascites Using a Specific Binding Agent of Human ANGIOPOIETIN-2 in Combination with a Taxane
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 11,872,282Treatment of Ovarian Cancer in Patients with Ascites Using a Specific Binding Agent of Human ANGIOPOIETIN-2 in Combination with a Taxane
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 10,301,391Bcma and CD3 Bispecific T Cell Engaging Antibody Constructs
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 10,781,264PSMA and CD3 Bispecific T Cell Engaging Antibody Constructs
In force
 · High confidence
Amgen Research (Munich) GmbHIn forceHigh confidence
US 11,434,302Bispecific T Cell Engaging Antibody Constructs
In force
 · High confidence
Amgen Research (Munich) GmbHIn forceHigh confidence
US 12,799,224Bispecific T Cell Engaging Antibody Constructs
In force
 · High confidence
Amgen Research (Munich) GmbHIn forceHigh confidence
US 10,088,660Imaging System for Counting and Sizing Particles in Fluid-Filled Vessels
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 10,539,773Imaging System for Counting and Sizing Particles in Fluid-Filled Vessels
In force
 · Medium confidence
Amgen Inc.In forceMedium confidence
71 more term ends in 2037 · Pro
10 of 81 patents shown. Soonest term end first, then patent number.
Pro members see all 81.
Upgrade to Pro
79 of these are in force and held by Amgen Inc..
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited